HSBlox's Blockchain Technology Advances Clinical Trial Sample Management with Increased Visibility, Transparency and Tracking

January 29, 2019 2 min read

Digital Sample Manager utilizes distributed ledger technology to ensure sample tracking and real-time status updates

ATLANTA, Jan. 29, 2019 /PRNewswire/ -- HSBlox, a technology company that is bringing innovation and transparent economics to the healthcare ecosystem, today announced the launch of its Digital Sample Manager (DSM) solution, which leverages blockchain (distributed ledger technology or DLT) to bring improved visibility, transparency and tracking to the chain of custody in clinical trials. The solution provides end-to-end sample tracking and real-time status updates to all chain of custody entities.

Maintaining visibility into the chain of custody is critical—as is providing the level of data integrity and traceability required by regulatory authorities. The chain of custody spans multiple stakeholders and disparate data systems, augmented by extensive processes at clinical sites. This can result in excessive manual data entry, the need for coordination between external and internal teams, frequent opportunities for error and difficult end-of-trial reconciliation.

"During clinical trials, multiple biological samples are collected at various clinical sites over an extended period of time," said Lynn Carroll, chief of strategy & operations for HSBlox. "Flawless administration of the chain of custody is critical to sample management because correct handling impacts both the course and results of clinical trials."

HSBlox's DSM solution provides sample tracking that ensures a streamlined and transparent process with multiple participants, as well as real-time status updates that can be tracked efficiently. The DLT solution provides immutable records through the process, which aids in compliance and audits. Additionally, receipt acknowledgement, reporting and reconciliation—along with standardization of the complete process—minimize the need for changes to existing workflows.

"DSM is ideally suited to provide complete transparency for clinical trial program administration for life science and research organizations," added Carroll. "HSBlox deploys its distributed ledger technology platform—and the use of smart contracts—to automate tracking and permissioned disclosures among stakeholders including: trial sponsors, clinical sites, labs, clinical research organizations, auditors, shippers, local and third-party labs, as well as patients."

About HSBlox
HSBlox brings patient-centric solutions to the healthcare ecosystem, combining machine learning and blockchain (distributed ledger technology) to address the healthcare industry's demand for secure, real-time information sharing and interventions. HSBlox deploys smart contracts to automate multi-party transactions, driving better outcomes for each stakeholder. For more information, visit www.hsblox.com.

Media Contact:
Linda Healan
Amendola Communications for HSBlox
404-725-7117
Lhealan@acmarketingpr.com

SOURCE HSBlox

Related Links
http://www.hsblox.com